1. Home
  2. HCM vs BBU Comparison

HCM vs BBU Comparison

Compare HCM & BBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • BBU
  • Stock Information
  • Founded
  • HCM 2000
  • BBU 2016
  • Country
  • HCM Hong Kong
  • BBU Bermuda
  • Employees
  • HCM N/A
  • BBU N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • BBU Engineering & Construction
  • Sector
  • HCM Health Care
  • BBU Consumer Discretionary
  • Exchange
  • HCM Nasdaq
  • BBU Nasdaq
  • Market Cap
  • HCM 2.5B
  • BBU 2.2B
  • IPO Year
  • HCM N/A
  • BBU N/A
  • Fundamental
  • Price
  • HCM $14.84
  • BBU $25.20
  • Analyst Decision
  • HCM Hold
  • BBU Buy
  • Analyst Count
  • HCM 1
  • BBU 6
  • Target Price
  • HCM $19.00
  • BBU $31.33
  • AVG Volume (30 Days)
  • HCM 90.6K
  • BBU 19.4K
  • Earning Date
  • HCM 07-30-2025
  • BBU 08-01-2025
  • Dividend Yield
  • HCM N/A
  • BBU 1.00%
  • EPS Growth
  • HCM N/A
  • BBU N/A
  • EPS
  • HCM 0.04
  • BBU N/A
  • Revenue
  • HCM $630,201,000.00
  • BBU $35,354,000,000.00
  • Revenue This Year
  • HCM $14.86
  • BBU N/A
  • Revenue Next Year
  • HCM $19.54
  • BBU N/A
  • P/E Ratio
  • HCM $66.84
  • BBU N/A
  • Revenue Growth
  • HCM N/A
  • BBU N/A
  • 52 Week Low
  • HCM $11.51
  • BBU $16.85
  • 52 Week High
  • HCM $21.50
  • BBU $26.75
  • Technical
  • Relative Strength Index (RSI)
  • HCM 46.89
  • BBU 58.90
  • Support Level
  • HCM $15.02
  • BBU $24.89
  • Resistance Level
  • HCM $18.00
  • BBU $25.46
  • Average True Range (ATR)
  • HCM 0.42
  • BBU 0.53
  • MACD
  • HCM -0.04
  • BBU -0.10
  • Stochastic Oscillator
  • HCM 31.45
  • BBU 53.10

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About BBU Brookfield Business Partners L.P. Limited Partnership Units

Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.

Share on Social Networks: